MDSCs are capable of secreting MMP9 for promoting the anti-PD1 resistance cleavage of PD-L1 surface expression, which is dependent of MMP9 [36], and hypoxia restricts the anti-tumor function exhibited by anti-PD1 Abs. The gene discussed is MMP9; the disease is neoplasm.